The evidence that INNO-406 mediated c-Abl inhibition and consequent inhibition of the phosphorylation of parkin, and the observation that restoration of parkin’s function is protective, suggests a promising approach for further assessment in the treatment of PD. This evidence concerns the gene ABL1 and Parkinson disease.